This study was undertaken to test the hypothesis that short term exposure (4 hours) to physiologic hyperinsulinemia in normal, healthy subjects without a family history of diabetes would induce a low grade inflammatory response, independently of glycemic status. Twelve normal glucose tolerant subjects received a 4 hour euglycemic hyperinsulinemic clamp with biopsies of the vastus lateralis muscle. Microarray analysis identified 121 probe sets that were significantly altered in response to physiologic hyperinsulinemia while maintaining euglycemia. In normal, healthy human subjects insulin increased the mRNAs of a number of inflammatory genes (CCL2, CXCL2 and THBD) and transcription factors (ATF3, BHLHB2, HES1, KLF10, JUNB, FOS, and FOSB). A number of other genes were upregulated in response to insulin including RRAD, MT, and SGK. CITED2, a known coactivator of PPAR-alpha, was significantly downregulated. SGK and CITED2 are located at chromosome 6q23, where we previously detected strong linkage to fasting plasma insulin concentrations. We independently validated the mRNA expression changes in an additional 5 subjects, and closely paralleled the results observed in the original 12 subjects. A saline infusion in healthy normal glucose tolerant subjects without family history of diabetes demonstrated that the genes altered during the euglycemic hyperinsulinemic clamp were due to hyperinsulinemia and were unrelated to the biopsy procedure per se. The results of the present study demonstrate that insulin acutely regulates the levels of mRNAs involved in inflammation and transcription, and identifies several candidate genes, including HES1 and BHLHB2, for further investigation.
Introduction
Insulin resistance is a common pathologic state associated with obesity, hypertension, atherosclerotic cardiovascular disease and type 2 diabetes mellitus (1) . This cluster of abnormalities, referred to as the insulin resistance or metabolic syndrome, is thought to be related to the underlying insulin resistance (2) . Despite the severe impairment in insulin action in insulin resistant states, glucose tolerance remains normal because the pancreatic beta cells are able to augment their insulin secretory capacity to offset the insulin resistance (3, 4) .
Hyperinsulinemia (increased insulin levels) occurs as a result of the increase in insulin secretion from the beta cells. Over time, the excessive rates of insulin secretion cannot be maintained, leading to the development of glucose intolerance and type 2 diabetes (1, 4).
Despite intensive investigation, the underlying cause of insulin resistance remains unknown. Many cellular defects have been shown to contribute to the pathophysiology of insulin resistance in type 2 diabetes, including impaired insulin signaling (5, 6) , reduced insulinstimulated glucose uptake, decreased hexokinase II expression and activity, diminished glycogen synthase activity, and decreased pyruvate dehydrogenase activity (7) (8) (9) (10) (11) (12) . Impaired mitochondrial function has been associated with an increase in toxic lipid metabolites (FACoA, DAG, ceramide) in skeletal muscle of subjects with prediabetes and type 2 diabetes and these toxic lipid metabolites have been implicated as a cause of the insulin resistance (13) (14) (15) (16) (17) . We previously reported that a physiologic increase in plasma FFA concentration in normal healthy subjects resulted in changes in gene expression in skeletal muscle that are consistent with an inflammatory response (18). In addition, we also demonstrated that changes in the composition of the extracellular matrix are a general characteristic feature of insulin-resistant muscle (19).
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Insulin has been shown to be a risk factor for the development of atherosclerotic cardiovascular disease (1) . The effects of insulin on arterial tissues include proliferation of smooth muscle cells, enhanced cholesterol synthesis and low-density lipoprotein-receptor activity, increased formation and decreased regression of lipid plaques, stimulation of connective tissue synthesis and stimulation of growth factors (1) . In the present study, we set out to test the hypothesis that short term exposure (4 hours) to physiologic hyperinsulinemia in normal glucose tolerant healthy subjects without a family history of diabetes would induce a low grade inflammatory response, independently of glycemic status, in skeletal muscle. By combining the euglycemic insulin clamp technique (20) with microarray profiling, we tested this hypothesis and, at the same time, identified novel pathways that are regulated by insulin in skeletal muscle.
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Materials and Methods
Subjects: Healthy, normal glucose tolerant subjects without a family history of diabetes participated in the study. All subjects were free of any organ system disease as determined by medical history, physical examination, screening chemistries, complete blood cell count, urinalysis, and electrocardiogram. Normal glucose tolerance was established by a 75 g oral glucose tolerance test performed one week prior to the clamp study. Percent body fat was determined by DEXA using a Hologic Delphi A scanner (Hologic, Inc., Bedford, MA). Subjects
were not taking any medications and demonstrated stable body weight (± 3lbs) over the 6 months prior to the study. None of the subjects participated in any heavy exercise, and they were instructed not to exercise for 3 days before the study. All subjects gave informed written consent prior to their participation in the study. The study protocol was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio.
Study design: All subjects consumed a weight maintaining diet containing 50%
carbohydrate, 35% fat, and 15% protein over the 3 days prior to study and were instructed not to participate in any heavy exercise. After a 10 hour overnight fast, all subjects reported to the General Clinical Research Center (GCRC) at 0800 h and catheters were placed into an antecubital vein (for infusion of all test substances) and retrogradely into a vein on the dorsum of the hand (for blood withdrawal). The hand was placed in a heated box (65°C) to achieve arterialization of the venous blood. Twelve subjects received a 4 hour euglycemic, hyperinsulinemic (80 mU/m 2. min) clamp, which was performed with infusion of 3-3 H-glucose to determine rates of glucose appearance and disposal, as previously described (5, 20 minutes of the insulin infusion, as previously described (5) . A control saline (0.2 ml·m-2·min-1)
infusion was performed in three additional subjects, with a vastus lateralis muscle biopsy taken basally and at the end of the saline infusion. After completion of the microarray/RT-PCR determinations (see below), we studied an additional 5 subjects to validate our original observations. These 5 subjects received a 3 hour euglycemic hyperinsulinemic (80 mU/m 2. min)
clamp with tritiated glucose, as described above. Vastus lateralis muscle biopsies were performed at -60 minutes and after 180 minutes of insulin infusion. Muscle biopsy specimens (~200 mg) were frozen immediately in liquid nitrogen and stored until processed.
Muscle biopsy processing:
Muscle biopsies from each subject were homogenized in RNAStat solution (Tel-Test Inc., Friendswood, TX), using a Polytron homogenizer (Brinkmann Instruments Westbury, NY). Total RNA was purified with RNeasy and DNase I treatment (Qiagen, Chatsworth, CA). RNA isolated from the insulin infusion biopsies were used in the microarray and quantitative RT-PCR studies described below. The RNA isolated from the control saline infusion biopsies was used for the quantitative RT-PCR studies. 
Quantitative real time PCR (QRT-PCR).
Muscle expression of various genes was determined using a one-step QRT-PCR from total RNA (Applied Biosystems 7900HT). The quantity of mRNA for each gene of interest for each sample was normalized to that of 18S ribosomal RNA using the comparative (2 -CT ) method as described previously (18). Statistical comparisons were done using paired t-tests. Sequences of the primers and probes used for mRNA quantification by QRT-PCR can be supplied upon request.
Substrate and hormone determinations: Plasma glucose concentration was determined
by the glucose oxidase method on a Beckman Glucose Analyzer (Beckman Instruments, Fullerton, CA). Plasma insulin was determined by radioimmunoassay (Diagnostic Products
Corp., Los Angeles, CA). Plasma tritiated glucose specific activity was determined on Somogyi precipitates of plasma as previously described (23).
Statistical Analysis: Data were expressed as the means ± SEM. Statistical significance of the difference between means was determined using paired or non-paired Student's t-tests, where appropriate. Correlations were analyzed using Pearson's product moment test. For all analyses, a P < 0.05 was considered to be statistically significant. Statistical analysis of microarray data and QRT-PCR data were described above.
Results
Subjects:
Twelve healthy subjects without a family history of diabetes (5 females Table 4 ).
Of note, one of these genes was thioredoxin interacting protein (TXNIP), which has been implicated in insulin-stimulated peripheral glucose uptake in humans (22). The results of the present study indicate that most of the detectable changes occurred 30 minutes after the start of insulin.
Functional classification of genes:
Gene functional classification clustering analysis was performed in DAVID on the genes that were upregulated (n=93) by insulin. Four functional groups were identified from the list of upregulated genes: (i) transcription binding, activity and regulation, (ii) protein kinase activity, (iii) inflammation and chemokine activity, and (iv) metal ion binding (Table 1) . Additional information on the clustering of the genes in each group is displayed in Supplementary Fig. 1-4 . No functional groups were identified for the 4 genes downregulated by insulin.
EASE analysis on the genes that were upregulated (n=93) by insulin yielded 42 significant gene categories, divided amongst 3 gene ontology (GO) systems: biological process (n = 28), cellular component (n = 1), and molecular function (n = 13). The gene categories identified for each significant GO system are depicted in Supplementary Table 5 . Briefly, for the biological process system, the majority of the genes coded for proteins involved in cell growth (50%) and regulation of transcription (31%). In addition, genes in the molecular function system were involved in RNA/DNA binding (74%) and transcription (33%). The only cellular component system identified was the nucleus, where 43% of the genes were localized.
The chromosomal location of the differentially expressed genes following insulin infusion was determined using the program Onto-Express. The location of the insulin-regulated genes was distributed amongst all chromosomes except Y, 13 and 7. Statistical analysis performed in Onto-Express yielded no chromosome that contained more insulin-regulated genes than expected ( Supplementary Fig. 5 ).
Insulin-signaling gene analysis:
Because the microarray analysis identified significant increases in some genes involved in the insulin signaling pathway including RRAD, KRAS, Table 1) , we looked at the microarray expression values of other insulin-signaling genes. Following 240 minutes of insulin infusion, the expression of 24 insulin-signaling genes increased (all P < 0.05, without correcting for multiple testing) ( Table 2 ).
KLF10 and FOS (Supplementary
Many of these mRNA expression changes did not achieve statistical significance when corrected for multiple testing. Table 6 ). Similarly, BHLHB2 and MT1H mRNAs were both significantly increased in diabetic subjects compared to normal glucose tolerant subjects when we analyzed the dataset of Mootha et al. (17) .
Analysis of published datasets:
Correlations of microarray data with subject characteristics: To identify associations between insulin-regulated gene expression and insulin-stimulated glucose disposal, we performed correlation analysis using the Pearson's product moment test. Insulin-stimulated whole body (primarily represents muscle) glucose disposal was strongly and inversely correlated with ADH1B, CYR61 and BHLHB2 mRNA expression (r = -0.74, -0.65 and -0.57, respectively). We also observed a negative correlation between basal EGP and SGK mRNA expression (r = -0.74, P < 0.01), while DNAJB1, HBEGF and TRIB1 mRNA gene expression was strongly correlated with fasting plasma insulin concentration (r = 0.74, 0.65 and 0.58, respectively). These and other correlations are depicted in Supplementary Table 7 .
QRT-PCR analysis to confirm microarray data: To validate the microarray data, we quantitated the changes in mRNA levels of 20 genes (18 of which increased and 2 of which decreased) using QRT-PCR in the twelve subjects who received a 4 hour euglycemic hyperinsulinemic clamp. These genes displayed wide differences in their response to insulin on the microarray (from -2.3 to 7.7-fold change). The correlation coefficient (r) between the genes quantitated by QRT-PCR and microarray analysis was 0.79 (P < 0.01) (Supplementary Fig. 6 ).
Of note, the QRT-PCR fold changes were larger than the changes observed with microarray analysis. This is consistent with previous studies from our laboratory in which microarray analysis tends to underestimate the changes in gene expression (18). In addition, we independently validated the mRNA expression changes in an additional five subjects who received a 3 hour euglycemic hyperinsulinemic clamp. mRNA expression in these 5 subjects, who were studied after the microarray/QRT-PCR analyses were completed in the first 12 subjects, closely paralleled that in the original 12 individuals (Table 3) . We also observed significant inter-individual variation in the basal mRNA levels in these normal, healthy subjects.
This natural variation in mRNA expression most likely represents the complex interplay of intrinsic (i.e. age, sex, ethnicity and genes), physiological and environmental factors. This observation is consistent with other studies that have identified significant inter-individual variation in basal mRNA expression in healthy subjects (26-28).
QRT-PCR analysis performed on control saline infusion samples:
To verify that the changes observed during the insulin clamp were due to insulin action on the muscle, and not due to the biopsy procedure per se, we performed QRT-PCR analysis on the muscle biopsies from subjects who received saline infusion. For this study, we analyzed the same genes that were used to validate the insulin infusion microarray analysis. The results of the saline infusion study are presented in Table 4 . Of the 20 genes examined, 3 genes were significantly altered compared to the basal state. ETS2 and RRAD mRNA levels were significantly increased during the saline infusion by 1.24 ± 0.03 and 1.78 ± 0.09, respectively (both P < 0.05), but the changes were quantitatively much less than the fold increases observed in the insulin infusion group (Table 3) .
Likewise, the significant decrease in EGR1 mRNA expression in the control saline infusion (-3.57 ± 2.30 fold change) was contrary to the significant increase observed during insulin infusion (Table 3) .
Discussion
The present study was undertaken in part to test the hypothesis that short term exposure (4 hours) to physiologic hyperinsulinemia in normal, healthy subjects without a family history of diabetes would induce a low grade inflammatory response, independently of glycemic status. To test this hypothesis subjects received an 80 mU/m 2. min euglycemic hyperinsulinemic clamp with vastus lateralis muscle biopsies performed before, during and at the end of the insulin clamp.
The concentration of insulin (~560 pmol/liter) achieved during the insulin clamp was within the high physiological range, as described elsewhere (29), and was similar to that observed during an oral glucose/meal tolerance test, although we infused insulin for 4 hours, which is longer than the usual tissue exposure to insulin following a meal in normal, healthy subjects. Therefore, we believe that the results in the present study have relevance to the effects of physiologic hyperinsulinemia on muscle mRNA expression and may provide insights into the etiology of insulin resistance in type 2 diabetes and obesity (1).
The uniqueness of the present study compared to previous studies (9, 22, 24, 25, 30-33) is the inclusion of a control saline infusion group and validation of the results in a separate group of individuals. In our study, we felt that it was important to demonstrate that the observed changes in mRNA expression during the insulin infusion clamp were independent of the biopsy procedure per se, which could have led to increased mRNA expression of some genes involved in inflammation. The results of the saline infusion study clearly demonstrate that the genes altered during the euglycemic hyperinsulinemic clamp were due to insulin and independent of the muscle biopsy procedure
The results of the present study demonstrate that a number of genes involved in inflammation were upregulated. Thrombomodulin, which is dysregulated during inflammation, and in common with those in the present study. Of particular note, we found that increased mRNA expression of HES1 and BHLHB2 was replicated in the majority of the datasets analyzed (22, 24, 25). Reduced insulin-mediated glucose disposal in skeletal muscle is a common metabolic feature of type 2 diabetes (4-6). In the present study, we observed an inverse relationship between BHLHB2 expression and whole body (primarily reflects muscle) glucose disposal rate. Moreover, we observed that the mRNA expression of HES1 and BHLHB2 was increased in muscle tissue of type 2 diabetic subjects (16, 17) . Collectively, the HES1 and BHLHB2 mRNA expression results suggest that these two genes may be involved in the insulin resistant phenotype observed in type 2 diabetes. However, the exact mechanism of action of the HES1 and BHLHB2 genes in skeletal muscle requires further investigation.
Oxidative stress has been implicated in the development of insulin resistance and microvascular/macrovascular complications in patients with type 2 diabetes (34).
Metallothioneins (MTs) are cysteine-rich, low molecular weight intracellular proteins that have been shown to regulate the metabolism of metals and to be efficient scavengers of reactive oxygen species (ROS) (35, 36) . In the present study, functional analysis using DAVID identified a group of MT mRNAs, whose expression is increased following insulin stimulation.
Furthermore, analysis of the Parikh et al. dataset identified a significant increase in expression of the mRNA for MT1H during a 2 hour euglycemic hyperinsulinemic clamp (22). We also observed an increased mRNA expression of MT1H in muscle tissue of type 2 diabetic subjects (17), although opposite findings have been reported elsewhere (31) . Another study, found no differences in MT mRNA levels when comparing type 2 diabetic groups to control groups (36) . Insulin modulates intracellular metabolism by regulating pathways involved in protein, glycogen, and fat metabolism. In skeletal muscle, insulin stimulates glucose uptake, glycogen synthesis, and glucose oxidation (4) . In the present study, we show that insulin increased the expression of a number of mRNAs in the phosphoinositol-3 kinase (metabolic) and MAP kinase (mitogenic) pathways (Table 2 ). In addition to the insulin receptor, IRS2, regulatory/catalytic subunits of PI3-K kinase and hexokinase-2, in particular, the ras-related associated with diabetes gene (RRAD) was increased following insulin stimulation and similar findings have been reported by other groups (9, 32) . RRAD is overexpressed in the skeletal muscle of type 2 diabetes subjects (31, 37) , and has been implicated in the pathogenesis of insulin resistance in type 2 diabetes. RRAD is involved in the classical MAP kinase pathway, which is an integral component of the insulin-signaling cascade and has been implicated in the development of atherosclerosis (38) . We hypothesize that the increase in RRAD observed by previous investigators and in the present study may represent a response to the compensatory hyperinsulinemia that occurs as the beta cell attempts to offset the insulin resistance. RRAD may provide a link between insulin resistance, hyperinsulinemia, and atherosclerosis (1).
Insulin, as well as insulin-like growth factor, serum, and glucocorticoids, stimulate serum/glucocorticoid regulated kinase (SGK) activity by a mechanism requiring the participation and activation of phosphatidylinositol 3-kinase (PI3-K) (39, 40) . We demonstrate in the present study that muscle mRNA expression of SGK is significantly increased by insulin in normal healthy subjects, and that its expression was negatively correlated with basal endogenous glucose production. To our knowledge, this result has not been replicated in any other microarray study.
However, it has been shown elsewhere that SGK transcription is markedly enhanced in diabetic nephropathy (39) . Interestingly, the SGK gene has been localized to chromosome 6q23, a major locus associated with fasting insulin concentrations and insulin resistance in Mexican Americans from the San Antonio Family Diabetes Study (41) . These results suggest a potential role for SGK in insulin resistance in type 2 diabetes and other insulin resistant states.
CREB/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 (CITED2) also is located at 6q23, and in the present study was downregulated by insulin.
CITED2 interacts with the cAMP-responsive element-binding protein (CBP)/p300, TFAP2, Lhx2, and nuclear receptors, such as peroxisome proliferator-activated receptor and estrogen receptor, to function as a transcriptional modulator (42) . Another chromosomal region that has been linked with insulin resistance, type 2 diabetes and obesity is 10q24-25 (43). The peroxisome proliferative activated receptor, gamma, coactivator-related 1 (PPRC1) is located at 10q24.32 and was found to be significantly upregulated by insulin in the present study. PPRC1
was first identified in database searches for sequences with similarities to peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1 (PGC1) (44) . PGC1 is a transcriptional regulator that activates (in conjunction with nuclear respiratory factor-1 and PPAR-alpha), PPAR-gamma, hepatocyte nuclear factor 4, and other transcription factors which are key metabolic regulators. PPRC1 is a growth-regulated coactivator that may coordinate the activities of multiple transcription factors required for cell growth (44) . The exact role of the CITED2 and PPRC1 genes remains unclear and further studies will be needed to understand their role in insulin signaling.
In summary, we have demonstrated that a sustained physiologic increase in the plasma insulin concentration for as little as 4 hours in non-exercised subjects alters the levels of multiple muscle mRNAs, including inflammatory factors, which may be involved in the development of insulin resistance in type 2 diabetes mellitus. Of note, several of these genes are localized to chromosomal regions that previously have been shown to be associated with type 2 diabetes, insulin resistance, obesity and atherosclerosis. Table 3 . Results of the microarray with those of QRT-PCR following insulin infusion.
a More than one probe set was significantly altered for this gene on the microarray. The probe set with the greatest fold change in the microarray analysis is represented here (data taken directly from Supplementary Tables 1 and 2) . Significance for the genes selected for QRT-PCR was assessed looking at each dataset separately and using the Student's paired t test. 
